Navigation Links
WallSt.net Announces Upcoming Interview With CEO of Biomoda
Date:9/26/2007

NEW YORK, Sept. 26 /PRNewswire/ -- John Cousins, President and Chief Executive Officer of Biomoda, Inc. (OTC Bulletin Board: BMOD) (http://www.biomoda.com) will be featured in an exclusive interview with http://www.wallst.net scheduled for September 28 at 1 p.m. EDT. The interview will be posted on http://www.wallst.net by 8 p.m. EDT on September 28.

The interview will cover topics including Biomoda's market potential, growth initiatives, competitive edge, recent news, and milestones for which investors should watch.

To hear the interview in its entirety, visit http://www.wallst.net and click on "Interviews." The interview can be accessed either by locating the company's ticker symbol under the appropriate exchange at the top of the "Interviews" section or by entering the company's ticker symbol in the Search Archive window on the right-hand column of the "Interviews" section.

About Biomoda:

Biomoda is committed to the vision that the early detection of cancer is achievable in our lifetime. Through the developments of our technologies and an array of complimentary business models, Biomoda is creating diagnostic tools to assist clinicians in early detection, staged diagnosis and aid in determining therapy routes. Biomoda's prototype tests are inexpensive, simple and accurate. Our business plan is to focus on economically large markets where our proprietary, patented technology will significantly reduce overall costs in the healthcare system and improve patient outcomes. At Biomoda, our mission is to create and market new diagnostic solutions for the early detection and clinical management of cancer; solutions that provide compelling value to the healthcare system through cost savings and improved patient outcomes.

For more informatio
'/>"/>

SOURCE Financial Filings Corp.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Speaker announces business members of IT Task Force
2. Doyle announces technology tax credits for Berbee
3. Doyle announces new energy, global warming policies
4. Doyle announces $80M renewable energy strategy
5. GE announces first installation of Discovery VCT
6. UWM announces winners of RGI awards
7. Third Wave announces two senior management appointments
8. Mirus announces new method for making antibodies
9. Merge announces sofware updates, upcoming acquisition
10. Small Tree announces ethernet solution for Apple Xserv G5
11. TEKLYNX International announces new RFID software

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/27/2009)..., DURHAM, N.C., Nov. 27 Cromoz Inc...e water-soluble carbon nanotube-based cancer drug ...uble carbon nanotubes, which have functional group...ncer drugs, was developed in partnership with the ...arbon nanotubes serves as a drug delivery vehicle ...
(Date:11/25/2009)..., BOSTON, Nov. 25 Biotech firm Rep...nomic data from the 1918 pandemic through the pred... pandemic, today issued its latest biochemical ana...thality of the H1N1 ("Swine Flu") virus has droppe...,s current outbreak in the spring of 2009 to resti...
(Date:11/25/2009)..., NEW YORK, Nov. 25 Reportlinker.c...available in its catalogue: ,, Brazil Bioethan...ttp://www.reportlinker.com/p0165503/Brazil-Bioetha..., Brazil Bioethanol Market Analysis and Forecast...s detailed analysis and forecasts of the global bi...
(Date:11/24/2009)... The New York investment bank KTA Capital... agreed an AU$6.7 mil convertible note private pla...vate placement was arranged by KTA Capital as Neur... New York (PRWEB) November 23,...KTA Capital, LLC ("KTA Capital") has ann...
Breaking Biology Technology:North Carolina Based Cromoz Inc. Launches Carbon Nanotechnology for Target Drug Delivery System in Cancer Treatment in Hyderabad, India 2Biological H1N1 Vaccines: Too Little, Too Late 2Biological H1N1 Vaccines: Too Little, Too Late 3Biological H1N1 Vaccines: Too Little, Too Late 4Biological H1N1 Vaccines: Too Little, Too Late 5Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 2Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 3Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 4Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 5Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 6Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 7Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 8Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 9Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 10KTA Capital Arranges an AU$6.7 Million Private Placement by Neuren Pharmaceuticals 2
...nition of Myocardial Infarction provided jointly b...TOKYO and INDIANAPOLIS, May 21 Investigators from...w classification system for the Universal Definiti...study and showed that patients with acute coronary...intervention (PCI) and taking prasugrel, as compar...
... Spain, May 20 InspireMD, Ltd. announced today,th...Guard(TM) in Acute,Myocardial). The trial was desi...d performance of MGuard when used during Primary P... multicenter, prospective, single arm, 60 patients... Jagiellonian University,Krakow, Poland). Primary ...
...eripheral neuropathic pain in non-diabetic adults ...asdaq: NGSX ), a biopharmaceutical company focus...nagement therapies, announced today that the Europ...orization of Qutenza(TM) 179 mg cutaneous patch (f...neuropathic pain in non-diabetic adults either alo...
Other Biology Technology:Multiple Types of Heart Attacks Reduced by Prasugrel in TRITON-TIMI 38 Trial 2Multiple Types of Heart Attacks Reduced by Prasugrel in TRITON-TIMI 38 Trial 3Multiple Types of Heart Attacks Reduced by Prasugrel in TRITON-TIMI 38 Trial 4Multiple Types of Heart Attacks Reduced by Prasugrel in TRITON-TIMI 38 Trial 5Multiple Types of Heart Attacks Reduced by Prasugrel in TRITON-TIMI 38 Trial 6InspireMD Announce the Completion of Enrollment for the MAGICAL Trial (MGuard(TM) in Acute Myocardial Infarction) at EuroPCR '09. Results Will be Presented May 21st by Dr. Dariusz Dudek at the InspireMD Cocktail Reception Debate Chaired by Prof. Martin Le 2InspireMD Announce the Completion of Enrollment for the MAGICAL Trial (MGuard(TM) in Acute Myocardial Infarction) at EuroPCR '09. Results Will be Presented May 21st by Dr. Dariusz Dudek at the InspireMD Cocktail Reception Debate Chaired by Prof. Martin Le 3NeurogesX Receives European Commission Approval for Qutenza(TM) 2NeurogesX Receives European Commission Approval for Qutenza(TM) 3NeurogesX Receives European Commission Approval for Qutenza(TM) 4NeurogesX Receives European Commission Approval for Qutenza(TM) 5
(Date:11/25/2009)...st as vital to your health as what you eat, found ...tudies. Their experiments in mice revealed that th... the liverthe body,s metabolic clearinghouseis mos...s circadian clock as conventional wisdom had it. ...large number of genes completely independent of th...
(Date:11/24/2009)... arteries from collapsing have been true life-save...er needed -- once the arteries are strengthened, t... choice but to leave them in place. , Prof. Meit...f Biomedical Engineering has developed a new paten...they,re needed, then dissolves. , "Our new compo...
(Date:11/24/2009)...ter of debate. A high-profile study a few years ag...ir carbon from trees and leaves, evidence for a ve...ecosystems. , But new research from the Universi...ue. Algae provide a much richer diet for fish and ...d this week in the Proceedings of the National Ac...
Breaking Biology News(10 mins):Feeding the clock 2Feeding the clock 3A coating for life 2Fish food fight: Fish don't eat trees after all, says new study 2Fish food fight: Fish don't eat trees after all, says new study 3Pennsylvania Schools Report Decrease in Bullying Behaviors 61526 1Pennsylvania Schools Report Decrease in Bullying Behaviors 61526 2Pennsylvania Schools Report Decrease in Bullying Behaviors 61526 3Lampooning of U S Healthcare is Just What the Doctors Ordered as RoboDoc Begins its DVD Rounds on November 24th 21 61523 1Lampooning of U S Healthcare is Just What the Doctors Ordered as RoboDoc Begins its DVD Rounds on November 24th 21 61523 2Mach 7 Technologies Releases New Revision of Flagship Keystone Suite 28TM 29 Enterprise Image Management Platform 61520 1Mach 7 Technologies Releases New Revision of Flagship Keystone Suite 28TM 29 Enterprise Image Management Platform 61520 2
...glassy-winged sharpshooter consumes only the dilut...ifornia, which is feverishly working to prevent th...n a surprising study published in the June 6 issue...y), researchers at The Institute for Genomic Resea...olleagues have discovered that the sharpshooter,s ...
...lls, own ability to correct themselves, will be ou...ference of the European Society of Human Genetics ...lacing a faulty gene (commonly referred to as gene... the therapeutic potential that already exists in ...he Institute of Human Genetics, University of Colo...
...a enables shorter image acquisition times, provide...iagnostic procedures using simultaneous multi-isot...ize functional imaging, according to results relea...ego. , "The potential of using more than one trac...that more than one medical condition can be search...
Other Biology News:Surprising symbiosis: Glassy-winged sharpshooter eats with friends 2Surprising symbiosis: Glassy-winged sharpshooter eats with friends 3'Smart' genetic therapy helps the body to heal itself 2'Smart' genetic therapy helps the body to heal itself 3'Smart' genetic therapy helps the body to heal itself 4Patients to benefit from novel technology revolutionizing high-speed molecular imaging 2Patients to benefit from novel technology revolutionizing high-speed molecular imaging 3
Guinea Pig Complement from Pel-Freez Biologicals
Pro-mix l-[35S]in vitro cell labeling mix from GE Healthcare, formerly Amersham Biosciences
Flammable Chemical Cabinets, Justrite Model 25732 from South Coast Enterprises
cDNA Size Fractionation Columns from Invitrogen
Biology Products: